GLP‐1 agonists vs placeboHealth‐related quality of life · adults with Parkinson's disease1 finding from 1 reviewGLP‐1 receptor agonists for Parkinson's disease 2020 · Cochrane Headline outcomes onlyno estimate extracted1 study · 60 participantsLow